Invention Grant
- Patent Title: Mitochondrial epigenetic reprogramming and transplant
-
Application No.: US15714166Application Date: 2017-09-25
-
Publication No.: US10751375B2Publication Date: 2020-08-25
- Inventor: Craig M. Stolen , Allan Charles Shuros
- Applicant: Boston Scientific Scimed, Inc.
- Applicant Address: US MN Maple Grove
- Assignee: Boston Scientific Scimed, Inc.
- Current Assignee: Boston Scientific Scimed, Inc.
- Current Assignee Address: US MN Maple Grove
- Agency: Paul, DeVries Smith & Deffner LLC
- Main IPC: A61K35/545
- IPC: A61K35/545 ; A61K35/12 ; C12N5/074 ; C12N13/00 ; G01N33/50

Abstract:
Embodiments herein include methods for enhancing post-ischemic functional recovery through administration of mitochondria and related devices and methods. In an embodiment, a method for enhancing post-ischemic functional recovery is included. The method can include harvesting somatic cells from a patient or a donor, converting the somatic cells into induced pluripotent stem cells, extracting mitochondria from the induced pluripotent stem cells, and transplanting the mitochondria into the patient. Other embodiments are also included herein.
Public/Granted literature
- US20180085407A1 MITOCHONDRIAL EPIGENETIC REPROGRAMMING AND TRANSPLANT Public/Granted day:2018-03-29
Information query
IPC分类: